Bioporto AS (LTS:0JJM)
kr 1.22193 0 (0%) Market Cap: 640.19 Mil Enterprise Value: 568.47 Mil PE Ratio: 0 PB Ratio: 7.41 GF Score: 58/100

Q4 2022 Bioporto A/S Earnings Call Transcript

Mar 30, 2023 / 02:00PM GMT
Release Date Price: kr1.84
Operator

Greetings, and welcome to BioPorto Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Tony Pare. Thank you. You may begin.

Anthony P. Pare;S;CEO
BioPorto A

/-

Thank you, Rob, and thank you to everyone joining us today for our Q4 and full year 2022 financial results and business update call. Joining me today is Neil Goldman, BioPorto's Executive Vice President and Chief Financial Officer.

Before we begin, let me remind you that the company's remarks made during this conference call today, March 30, 2023, may include predictions, estimates and other information that may be considered forward-looking. For your information, I refer to our public filings.

Let's proceed. 2022 has been a remarkable year of progress and achieved milestones for BioPorto. The most significant is the submission of our de novo application to the U.S. Food and Drug Administration or FDA,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot